Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3152)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 15, 2023 (publication date) through May 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Papadopoulos KI, Papadopoulou A, Aw TC. MicroRNA-155 mediates endogenous angiotensin II type 1 receptor regulation: implications for innovative type 2 diabetes mellitus management. World J Diabetes 2023; 14(9): 1334-1340 [PMID: 37771329 DOI: 10.4239/wjd.v14.i9.1334] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i9/1334.htm |
| Number | Citing Articles |
| 1 |
K. I. Papadopoulos, A. Papadopoulou, T. C. Aw. Anexelekto (AXL) no more: microRNA-155 (miR-155) controls the “Uncontrolled” in SARS-CoV-2. Human Cell 2024; 37(3): 582 doi: 10.1007/s13577-024-01041-6
|